Yi Chen

Stock Analyst at HC Wainwright & Co.

(2.04)
# 1,225
Out of 4,460 analysts
375
Total ratings
29.81%
Success rate
-3.61%
Average return

43 Stocks

Co-Diagnostics
Jun 17, 2024
Reiterates: Neutral
Price Target: $2
Current: $1.53
Upside: +30.72%
Ocular Therapeutix
Jun 14, 2024
Reiterates: Buy
Price Target: $14
Current: $6.00
Upside: +133.33%
Belite Bio
Jun 13, 2024
Reiterates: Buy
Price Target: $59
Current: $48.82
Upside: +20.85%
Oculis Holding AG
Jun 11, 2024
Maintains: Buy
Price Target: $28$30
Current: $11.71
Upside: +156.19%
Applied DNA Sciences
Jun 10, 2024
Maintains: Buy
Price Target: $7$1.5
Current: $0.45
Upside: +236.32%
Anixa Biosciences
Jun 10, 2024
Maintains: Buy
Price Target: $12$7
Current: $2.43
Upside: +188.07%
Barinthus Biotherapeutics
Jun 7, 2024
Reiterates: Buy
Price Target: $8
Current: $1.59
Upside: +403.14%
IceCure Medical
Jun 5, 2024
Reiterates: Buy
Price Target: $3
Current: $0.74
Upside: +303.66%
CareDx
May 31, 2024
Reiterates: Neutral
Price Target: n/a
Current: $13.62
Upside: -
Greenwich LifeSciences
May 22, 2024
Reiterates: Buy
Price Target: $36
Current: $15.90
Upside: +126.42%
AngioDynamics
May 22, 2024
Reiterates: Buy
Price Target: $14
Current: $5.73
Upside: +144.54%
Alpha Tau Medical
May 22, 2024
Reiterates: Buy
Price Target: $9
Current: $2.32
Upside: +287.93%
Kiora Pharmaceuticals
May 20, 2024
Reiterates: Buy
Price Target: $18
Current: $4.12
Upside: +336.89%
Kala Pharmaceuticals
May 17, 2024
Maintains: Buy
Price Target: $21$18
Current: $5.50
Upside: +227.27%
Genprex
May 17, 2024
Reiterates: Buy
Price Target: $10
Current: $2.05
Upside: +387.80%
Alimera Sciences
May 16, 2024
Reiterates: Buy
Price Target: $6
Current: $3.04
Upside: +97.37%
REGENXBIO
May 15, 2024
Maintains: Buy
Price Target: $36$38
Current: $11.62
Upside: +227.16%
Tourmaline Bio
May 14, 2024
Reiterates: Buy
Price Target: $48
Current: $15.14
Upside: +217.04%
Sensus Healthcare
May 13, 2024
Maintains: Buy
Price Target: $8$10
Current: $5.14
Upside: +94.55%
EyePoint Pharmaceuticals
May 13, 2024
Maintains: Buy
Price Target: $33$30
Current: $8.43
Upside: +255.87%
Clearside Biomedical
May 13, 2024
Maintains: Buy
Price Target: $6$5
Current: $1.14
Upside: +338.60%
Veru Inc.
May 13, 2024
Reiterates: Buy
Price Target: $3
Current: $0.76
Upside: +293.65%
LifeMD
May 10, 2024
Reiterates: Buy
Price Target: $12
Current: $7.43
Upside: +61.51%
OPKO Health
May 8, 2024
Reiterates: Buy
Price Target: $3
Current: $1.25
Upside: +140.96%
ASLAN Pharmaceuticals
May 3, 2024
Reiterates: Buy
Price Target: $9
Current: $0.33
Upside: +2,600.27%
Bausch + Lomb
May 2, 2024
Reiterates: Buy
Price Target: $20
Current: $14.68
Upside: +36.29%
Zynex
May 1, 2024
Reiterates: Buy
Price Target: $21
Current: $9.10
Upside: +130.77%
OKYO Pharma
Mar 22, 2024
Maintains: Buy
Price Target: $6$7
Current: $1.23
Upside: +469.11%
Mainz Biomed B.V.
Mar 6, 2024
Maintains: Buy
Price Target: $5$3
Current: $0.57
Upside: +428.26%
ProPhase Labs
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $4.47
Upside: +146.25%
Motus GI Holdings
Sep 27, 2023
Reiterates: Buy
Price Target: $38
Current: $0.04
Upside: +99,900.00%
Nemaura Medical
Aug 21, 2023
Maintains: Buy
Price Target: $7$2.5
Current: $0.05
Upside: +4,910.02%
OpGen
Aug 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.42
Upside: -
Renalytix
Jun 30, 2023
Reiterates: Buy
Price Target: $5
Current: $0.49
Upside: +927.33%
Centogene
Jun 28, 2023
Reiterates: Buy
Price Target: $1.5
Current: $0.42
Upside: +257.14%
Check-Cap
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.14
Upside: -
Bio-Path Holdings
May 19, 2022
Maintains: Buy
Price Target: $240$180
Current: $2.44
Upside: +7,277.05%
DENTSPLY SIRONA
Apr 22, 2022
Maintains: Neutral
Price Target: $58$48
Current: $25.57
Upside: +87.72%
Interpace Biosciences
Nov 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.21
Upside: -
Eyenovia
Apr 1, 2021
Maintains: Buy
Price Target: n/a
Current: $0.66
Upside: -
Celcuity
Feb 17, 2021
Maintains: Buy
Price Target: n/a
Current: $15.24
Upside: -
CytoDyn
Apr 28, 2020
Reiterates: Buy
Price Target: n/a
Current: $0.14
Upside: -
Oragenics
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.43
Upside: -